|
Volumn 321, Issue 3, 2001, Pages 181-190
|
NSAIDs and the kidney revisited: Are selective cyclooxygenase-2 inhibitors safe?
|
Author keywords
Cyclooxygenase 1; Cyclooxygenase 2; Kidney; Potassium; Prostaglandins; Renal failure; Sodium
|
Indexed keywords
ANGIOTENSIN;
CELECOXIB;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
FENOPROFEN;
FLURBIPROFEN;
IBUPROFEN;
INDOMETACIN;
KETOPROFEN;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
NABUMETONE;
NAPROXEN;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTACYCLIN;
PROSTAGLANDIN;
PROSTAGLANDIN E2;
PROSTAGLANDIN F2;
PROSTAGLANDIN SYNTHASE;
RENIN;
ROFECOXIB;
SULINDAC;
THROMBOXANE A2;
TOLMETIN;
CHRONIC PAIN;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DRUG SELECTIVITY;
ENZYME LOCALIZATION;
HUMAN;
HYPERKALEMIA;
HYPONATREMIA;
INFLAMMATION;
INTERSTITIAL NEPHRITIS;
KIDNEY FAILURE;
KIDNEY FUNCTION;
KIDNEY PAPILLA NECROSIS;
NEPHROTIC SYNDROME;
NONHUMAN;
REVIEW;
STOMACH EROSION;
STOMACH PERFORATION;
STOMACH ULCER;
|
EID: 0035093123
PISSN: 00029629
EISSN: None
Source Type: Journal
DOI: 10.1097/00000441-200103000-00005 Document Type: Review |
Times cited : (41)
|
References (44)
|